Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 5/2011

01-05-2011 | Perspectives

Could Media Reports Include a Standardized Scale for Quality of Evidence?

Author: R. Scott Braithwaite, MD, MS, FACP

Published in: Journal of General Internal Medicine | Issue 5/2011

Login to get access

Abstract

While some media reports offer accurate interpretations of clinical research, other reports are misleading. The uneven accuracy of medical reporting may act in concert with its sheer volume to confuse the lay public about which health messages are most important and evidence-based. I outline one possible step towards a solution: medical journals can embed quality of evidence ratings in article summaries and create incentives for inclusion of these ratings in lay media reports.
Literature
1.
2.
Dentzer S. Communicating medical news–pitfalls of health care journalism. N Engl J Med. 2009;360:1–3.PubMedCrossRef
3.
Wilson A, Bonevski B, Jones A, Henry D. Media reporting of health interventions: signs of improvement, but major problems persist. PLoS ONE. 2009;4:e4831.PubMedCrossRef
4.
Bonevski B, Wilson A, Henry DA. An analysis of news media coverage of complementary and alternative medicine. PLoS ONE. 2008;3:e2406.PubMedCrossRef
5.
Holtzman NA, Bernhardt BA, Mountcastle-Shah E, Rodgers JE, Tambor E, Geller G. The quality of media reports on discoveries related to human genetic diseases. Community Genet. 2005;8:133–44.PubMedCrossRef
6.
MacKenzie R, Chapman S, Barratt A, Holding S. "The news is [not] all good": misrepresentations and inaccuracies in Australian news media reports on prostate cancer screening. Med J Aust. 2007;187:507–10.PubMed
7.
Schwitzer G. A statement of principles for health care journalists. Am J Bioeth. 2004;4:W9–13.PubMed
8.
Barton MB, Miller T, Wolff T, et al. How to read the new recommendation statement: methods update from the US Preventive Services Task Force. Ann Intern Med. 2007;147:123–7.PubMed
9.
Braithwaite RS, Roberts MS, Justice AC. Incorporating quality of evidence into decision analytic modeling. Ann Intern Med. 2007;146:133–41.PubMed
10.
11.
Kolata G. Years later, no magic bullet against Alzheimer's Disease. New York Times August 29, 2010.
12.
Schwartz LM, Woloshin S, Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009;150:516–27.PubMed
13.
Anonymous. Does the media support or sabotage health? Lancet 2009;373:604.
14.
Metadata
Title
Could Media Reports Include a Standardized Scale for Quality of Evidence?
Author
R. Scott Braithwaite, MD, MS, FACP
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 5/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1599-z

Other articles of this Issue 5/2011

Journal of General Internal Medicine 5/2011 Go to the issue

Healing Arts: Materia Medica

Round and Round

Editorials

Protecting the Public: Is It Time for a Paradigm Shift in Expected Practice Standards?

Original Research

Medical Tourism Services Available to Residents of the United States

Letters

Groups’ Use of Patient Experience Data

Original Research

Dosing of Unfractionated Heparin in Obese Patients with Venous Thromboembolism

Clinical Practice: Exercises in Clinical Reasoning

A Middle-Age Woman with Sudden Onset Dyspnea
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits